We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sorrento In-Licenses Four Biobetter and Biosimilar Antibodies

News   Aug 07, 2015

 
Sorrento In-Licenses Four Biobetter and Biosimilar Antibodies
 
 
 

RELATED ARTICLES

Nearly a Quarter of Antibiotic Prescriptions May Be Unnecessary

News

One in 10 children and about one in six adults with private insurance received antibiotics they didn’t need at least once in 2016, a new Michigan Medicine study suggests.

READ MORE

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

Human Blood Vessels Organoids a Model for Diabetes Research

News

This model will advance research in vascular diseases like diabetes, identifying a key pathway to potentially prevent changes to blood vessels—a major cause of death and morbidity among those with diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE